21 results
Shock and Vasoactive Drugs 
1) Determine type and etiology of shock
 • Distributive: Sepsis, Anaphylaxis, Neurogenic
Pericardial tamponade, Pulmonary ... vasoactive drug pharmacology ... #inopressors #diagnosis ... #management #comparison ... #table
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Vasopressors Table ... Blood Pressure, Pulmonary ... Vasopressors #Properties #Table ... #Pharmacology # ... Effect #Management
Pulmonary Embolism - Risk Stratification and Prognostication based on scores and clinical features

 • Bova score
Pulmonary Embolism ... Hemodynamics (Stable ... @nickmmark #Pulmonary ... prognostication #diagnosis ... #management #stratification
Amiodarone Toxicity and Monitoring

Tremor Ataxia 
Ocular neuritis 
Corneal Microdeposits 
Bradycardia 
Pulmonary fibrosis 
Hepatotoxicity 
Blue-gray skin
Bradycardia Pulmonary ... SideEffects #Adverse #Diagnosis ... #Management #Pharmacology
Blastomycosis (Blastomyces): Gilchrist’s disease, Chicago disease - Summary Sheet
 • Morphology
 • Geography, Reservoir and Mode
with an upper lobe ... blastomycosis • Diagnosis ... • Management ... #Blastomyces #diagnosis ... #management #summary
Differential diagnosis of Lymphangitic Carcinomatosis. 
On the left multiple diseases showing septal thickening:
1. Lymphangitic carcinomatosis: irregular
Differential diagnosis ... Cardiogenic pulmonary ... demarcated secondary lobeles ... Cardiogenic pulmonary ... Differential #Comparison #Table
Shock Classification
Shock Definition: State of cellular and tissue hypoxia due to: reduced oxygen delivery, increased oxygen
Cold and Dry) • Pulmonary ... embolism or severe pulmonary ... Classification #Types #diagnosis ... #management #cold ... warm #wet #dry #table
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
and Management ... Lung Abscess Management ... shows a small, stable ... Lung #Abscess #pulmonary ... differential #causes #management
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
mucoadhesive buccal tablet ... chew, or crush tablet ... Refer to product label ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
• HIV: 2/3 pulmonary ... Progression: • Upper lobe ... Tuberculosis Diagnosis ... Tuberculosis #TB #Diagnosis ... #Management #Treatment